Dr. Ebell and Dr. Wilkes discuss the POEM titled ' Majority of CIN2 regress in women aged 25 to 30 years '

Episode 646: Majority of CIN2 regress in women aged 25 to 30 years

Each week, Dr. Mark Ebell, POEMs Editor, joins Dr. Michael Wilkes, NPR correspondent and Vice-Dean of the UC-Davis Medical School, for a five minute discussion about an important recent medical study reviewed by the POEMs editors. POEMs provide synopsised reviews of studies that could affect a clinician's practice, and the discussion in this podcast provides additional depth and insight into the issue covered by the POEMs synopsis.  More about POEMs and it's companion point-of-care search tool, Essential Evidence Plus, at www.essentialevidenceplus.com.

Science & Medicine

Natural Sciences

Social Sciences

Medicine

Dr. Ebell and Dr. Wilkes discuss the POEM titled ' Monoclonal antibodies for Alzheimer disease: A lack of clinically meaningful benefits, plus significant harms '

Episode 695: Monoclonal antibodies for Alzheimer disease: A lack of clinically meaningful benefits, plus significant harms

Dr. Ebell and Dr. Wilkes discuss the POEM titled ' Patient reminders combined with clinician audit and feedback increases human papillomavirus vaccine uptake '

Episode 694: Patient reminders combined with clinician audit and feedback increases human papillomavirus vaccine uptake

Dr. Ebell and Dr. Wilkes discuss the POEM titled ' Canadian Thoracic Society guidelines for pharmacotherapy of stable chronic obstructive pulmonary disease '

Episode 693: Canadian Thoracic Society guidelines for pharmacotherapy of stable chronic obstructive pulmonary disease

Dr. Ebell and Dr. Wilkes discuss the POEM titled ' Scottish screening: 0 cases of invasive cervical cancer in women who received at least 1 dose of bivalent HPV vaccine at 12 or 13 years of age '

Episode 692: Scottish screening: 0 cases of invasive cervical cancer in women who received at least 1 dose of bivalent HPV vaccine at 12 or 13 years of age

Dr. Ebell and Dr. Wilkes discuss the POEM titled ' High-dose recombinant flu vaccine: NNT = 3000 to prevent one more infection, no impact on hospitalization '

Episode 646: Majority of CIN2 regress in women aged 25 to 30 years

Download our free app to listen on your phone